VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shot up 18.8% on Tuesday . The stock traded as high as C$0.10 and last traded at C$0.10. 501,450 shares were traded during mid-day trading, an increase of 204% from the average session volume of 165,136 shares. The stock had previously closed at C$0.08.
VentriPoint Diagnostics Stock Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The company has a market capitalization of C$15.93 million, a PE ratio of -4.75 and a beta of -0.41. The company has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.11.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- Where Do I Find 52-Week Highs and Lows?
- Office Suite Gets Pricier: Microsoft’s Bold Move Comes With Risk
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Big Blue’s Big Bet: IBM Buys AI Nervous System for $11B
- The Significance of Brokerage Rankings in Stock Selection
- Carvana Soars Over 10,000% From Lows—Now It’s in the S&P 500
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
